{
    "nctId": "NCT04616729",
    "briefTitle": "DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation",
    "officialTitle": "DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation in Breast Cancer Patients Undergoing Fertility Preservation: a Pilot Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Safety profile with regard to the risk of OHSS: assessment of change in ovarian volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\<36y\n* BMI \u2265 18 and \u2264 35 kg/m\u00b2\n* Early stage breast cancer\n* Any hormone receptor status\n* Any HER status\n* Cryopreservation of oocytes and/or embryos\n* Oncologist's approval to participate to the DEPO-trigger trial\n* Signed informed consent form\n\nExclusion Criteria:\n\n* Contra-indications for controlled ovarian stimulation or oocyte retrieval\n* Necessity of neo-adjuvant chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}